Share Name Share Symbol Market Type Share ISIN Share Description
Carclo Plc LSE:CAR London Ordinary Share GB0001751915 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 14.50p 14.00p 15.00p - - - 0 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 146.2 8.2 11.6 1.3 11.00

Carclo Share Discussion Threads

Showing 17751 to 17774 of 18100 messages
Chat Pages: Latest  712  711  710  709  708  707  706  705  704  703  702  701  Older
DateSubjectAuthorDiscuss
06/8/2018
14:51
What is up with the share price weakness? Makes me think the negotiations between Carclo and Consort Medical can not be going too well...
gordongekko4
04/8/2018
15:43
Another quiet week on the 8.3 front. Axxion continues to accumulate Carclo while Legal and General resumed selling down Consort, after the boost in its holding from the transfer in last week.
1gw
31/7/2018
12:51
Welcome queeny2. Appreciate your contributions to recent discussion here which, as a relative novice, I have been reading with interest.
gleach23
31/7/2018
12:27
gleach23 thank you, unaccountably I missed that reading on my phone. That's good. If auto-selling to cover tax liability is completely standard, with complete precedent, then that's fine in an offer period, to NOT do it would be wrong.
queeny2
31/7/2018
12:16
I see Axxion have bought more shares today
thechurch333
31/7/2018
11:55
Agree, very unusual. There may be something in the takeover code that allows him to sell to meet tax liabilities. Either that or the sale was pre-arranged and agreed by the board, so it has to go ahead. Don't think it tells us anything either way about bid talks.
thechurch333
31/7/2018
11:40
The RNS states that the sale of 30k shares is to cover the attendant tax liability on the 64k PSP shares that vested. The net result is a actually an increase in his holding of 34k shares.
gleach23
31/7/2018
11:12
I'm being thick I think - what's this sale by CEO of 30k shares at 118?Extremely unusual, is there an explanation?
queeny2
30/7/2018
11:12
Thanks 1gw
thechurch333
30/7/2018
07:32
On the 8.3 front, the main feature of last week's declarations for Carclo was that Axxion continued to increase, while River & Mercantile decreased. On the Consort side, main changes were Mirabaud decreasing due to a transfer out (which seemed to be picked up by Legal & General), while Blackrock and M&G increased. Legal & General sold Consort but this was more than balanced by the transfer in. E&OE.
1gw
27/7/2018
11:09
In addition to a host of trade buyers, there are probably a dozen private equity firms looking at Wipac right now. It is a good standalone business with decent revenue growth and margin recovery prospects. I'm sure the management team would be up for an LBO.
thechurch333
27/7/2018
10:43
The diveregent nature of CAR's activities is the main difficulty in arriving at an optimal valuation. Ideally it requires the simultaneous interest of two other parties, one for CTP, which we have, and one for Wipac. (I don't see the Bruntons/Jacottet business as a major obstacle.) No doubt the directors are working on this to maximise values (at least, one hopes so!) but it doesn't look that easy. The only UK company which immediately comes to mind is Dialight and I rather doubt they would bite. A larger group, ZKW group, based in Austria and with operations in the Czech Republic seem to be suppliers to much of the motor industry. Annual turnover about £1 billion and 10k employees (round figures). It could perhaps represent a step up into the premium range for them and the current low value of sterling could make it an attractive purchase. Any thoughts? HTTPS://zkw-group.com/en/home/company/locations/ HTTPS://zkw-group.com/en/home/company/key-figures/
boadicea
27/7/2018
07:43
Good news - the Vystra contract win is certainly a biggie given the need for these new facilities: Https://www.medicalplasticsnews.com/news/carclo-expands-operations-in-uk-with-new-facility/ "26 July 2018 Carclo expands operations in UK with new facility Injection moulder provider, Carclo Technical Plastics (CTP) has expanded its services in the UK with a new facility in Mitcham, Surrey. The new facility is dedicated to the manufacture of the BD Vystra disposable pen, used for the delivery of liquid pharmaceuticals. CTP worked with BD Medical to develop and scale-up the device. The new facility was opened by councillor Stephen Alambirtas and deputy mayor Judy Saunders from the London Borough of Merton. CTP has invested significantly in new manufacturing space, injection moulding machines, ancillaries and specialist staff in Mitcham to support this and other projects. CTP’s UK managing director Patrick Ward said: “Carclo Technical Plastics is a specialist contract manufacturer of disposable diagnostic and drug delivery devices for the global medical industry. The Vystra device underpins CTP’s continued growth within this sector.” Carclo has recently expanded its operations across the US, Czech Republic, China and India facilities as it continues its strategy of increasing its contract manufacturing business globally. Commenting, divisional chief executive officer Robert Stutzman said: “Carclo Technical Plastics has aggressive plans to continue developing our medical business, supported by Carclo’s engineering skills, global footprint and financial stability.”
rivaldo
24/7/2018
21:21
government brings in new takeover rules, won't affect this deal thou...
beeezzz
24/7/2018
11:37
Yes it gives them more time versus the alternative of CSRT going hostile this Friday, which moves the deal onto a fixed timetable of offer document between day 15 and day 28 following firm intention to bid announcement, defence document within 14 days of offer document, all quite speedy. Absent a counter-bid, or clear intention to break-up themselves in a way that maximises shareholder value (auction), the defence is non-existent of course, so Car wouldn't want to go there, it is not the route to shareholder value (or CEO package). The one set of motives I'd like to understand here is the Chair and CEO - how do they maximise their outcome, what do they want, because that will influence where we end up.
queeny2
24/7/2018
11:06
It was in my mind to question the extension to PUSU - it may work tactically as it's not just to Consort advantage it also gives Carclo more time to develop their defence as well as another month of improving performance and/or signing contracts. Maybe. cheers
illiswilgig
24/7/2018
09:06
Biggest risk for me is that Consort are limited in what they can offer. I don't like all-share offers as the price paid depends upon bidder's share price. Consorts has been dropping since the bid announcement suggesting some possible resistance to the deal? What would happen to Carclo's share price if Consort suddenly announced they were terminating discussions? That is the real risk...
kiwihope
23/7/2018
21:03
We're all clustered in the same place I think. Finding an adventurous counter bidder for whole thing tough, Really tough. With two larger more sophisticated companies I could invent all sorts of possible scenarios, but not so much here. I like the questioning whether early extension is bullish rather than early white flag. Nice thought. Will think on it. In my dreams Car and CSRT put led up for auction and Consort pay a fair price for CTP and that gets us to 200p, in my dreams.
queeny2
23/7/2018
20:38
I think I'm in a similar place. I can't see how Carclo could save face opening talks on the basis of an offer within 10% of the 116p they rejected out of hand, so I would expect Consort to have (indicatively) offered at least around 130p to get access to data and cooperation in evaluating the data. If negotiations and discovery don't throw up any roadblocks then there's the chance of a further move up to secure a recommendation as we near the PUSU deadline. But to get to the 150p+ I think we all think could ultimately be justified (by Consort to its shareholders), it needs some competition, or a really credible defence position such as an offer on the table for Wipac. I'm not sure I can see the logic in another company bidding for the whole of Carclo before Consort get to PUSU - most likely I think anyone thinking of bidding would wait to see if Consort and Carclo can reach agreement and if so at what price before they disclose their own hand. So Carclo, hopefully making use of a really good advisor, has to drum up as much interest as possible before agreeing to recommend Consort in the hope that someone then follows through with a counter-bid after Consort announce a recommended bid. So I suppose I'm looking at a most-likely case of a recommended offer around 130p or maybe slightly higher. You may be right queeny that on a probabilistic basis the expected outcome isn't much higher than it was before today, but deterministically it feels to me like we moved forward quite a long way with today's news and I remain surprised that the price didn't move further.
1gw
23/7/2018
17:49
I also added a few today. My observation is that it is early to ask for an extension to the PUSU as they still have a week to negotiate. Look at the IWG situation currently as an example where these things normally go down to the wire before an extension is requested. On balance I think it is bullish as it buys Carclo an extra 2 weeks to find alternative buyers. Consort most definitely want it and Carclo management have today indicated they know the game is up for them. I therefore think downside is limited. The most likely outcome is a bit higher than this (125-130p?), with a chance of decent upside in an auction (150p+).
thechurch333
23/7/2018
13:46
Undisturbed price 80p, stock has traded ten year low this year. I'm not sure when I've seen a bidder pay 100% premium unless either the defence is strong and plausible or a counter bidder emerges.
queeny2
23/7/2018
13:34
Managed to get 10k shares for between 117/18. Targeting minimum 1.50.
brucie5
23/7/2018
13:19
1gw so let's try and imagine what would need to be the case for a broadly unchanged share price to be correct price action .... My best shot is that while the news has removed downside it has also removed upside? In that scenario CSRT being compelled to go hostile produces a higher price, both in and of itself and also because it suggests a better defence is available to carclo.Whereas now we are likely on a tedious path to an agreed offer at an unexciting price so long as the execs at carclo are looked after. The power of CSRT's ballsy attitude has caused the white flag to go up very quickly.It's plausible? Under what scenario can you now dream of even 1x sales, a silly cheap multiple which is in fact 150p.So we all have to revise our probabilities attached to the varying outcomes, the net effect of which is small on how much the price should move on the news.
queeny2
23/7/2018
13:11
Not according to disclosed volume no :)
queeny2
Chat Pages: Latest  712  711  710  709  708  707  706  705  704  703  702  701  Older
Your Recent History
LSE
CAR
Carclo
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190718 07:15:03